VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer
187,133MODERNA
33,878JANSSEN
2,321PFIZER\BIONTECH
1,091GLAXOSMITHKLINE BIOLOGICALS
983UNKNOWN MANUFACTURER
363MERCK & CO. INC.
229SEQIRUS, INC.
45DYNAVAX TECHNOLOGIES CORPORATION
41NOVARTIS VACCINES AND DIAGNOSTICS
29SANOFI PASTEUR
18EMERGENT BIOSOLUTIONS
8PAXVAX
7TEVA PHARMACEUTICALS
4PFIZER\WYETH
3BERNA BIOTECH, LTD.
2SMITHKLINE BEECHAM
2INTERCELL AG
2PROTEIN SCIENCES CORPORATION
1CSL LIMITED

Incidents per State

State Total
77,548
AK1,869
AL5,581
AR3,688
AS47
AZ14,288
CA61,984
CO11,665
CT8,149
DC1,663
DE1,807
FL37,749
FM5
GA15,058
GU120
HI2,453
IA4,625
ID2,692
IL20,334
IN24,007
KS4,615
KY7,696
LA4,887
MA14,654
MD12,514
ME3,129
MH11
MI18,739
MN12,528
MO9,710
MP29
MS2,790
MT2,375
NC16,368
ND1,356
NE2,880
NH3,100
NJ17,634
NM3,916
NV4,239
NY34,355
OH19,081
OK6,195
OR8,636
PA23,083
PR2,370
QM2
RI2,088
SC6,411
SD1,212
TN9,131
TX35,174
UT4,273
VA14,937
VI64
VT1,676
WA14,909
WI11,259
WV2,388
WY861
XB5
XL1
XV2

ID: 1572053
Sex: F
Age:
State: FL

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: hardness in the injection site; rash in the injection site; redness in the injection site; headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (hardness in the injection site), VACCINATION SITE RASH (rash in the injection site), VACCINATION SITE ERYTHEMA (redness in the injection site) and HEADACHE (headache) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. (77/11)20A) for COVID-19 vaccination. No Medical History information was reported. On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jan-2021, the patient experienced VACCINATION SITE INDURATION (hardness in the injection site), VACCINATION SITE RASH (rash in the injection site), VACCINATION SITE ERYTHEMA (redness in the injection site) and HEADACHE (headache). At the time of the report, VACCINATION SITE INDURATION (hardness in the injection site), VACCINATION SITE RASH (rash in the injection site), VACCINATION SITE ERYTHEMA (redness in the injection site) and HEADACHE (headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Treatment for the event included Tylenol, Ibuprofen and icing the injection site. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1572054
Sex: M
Age:
State: TX

Vax Date:
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: This spontaneous case reported by a consumer, describes the occurrence of feeling abnormal (right arm was inarticulate really bad), headache (severe headache), myalgia (body aches) and nausea in a male patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received a dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced feeling abnormal (right arm was inarticulate really bad), headache (severe headache), myalgia (body aches) and nausea. At the time of the report, feeling abnormal (right arm was inarticulate really bad), headache (severe headache), myalgia (body aches) and nausea outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. Concomitant product use and treatment information not provided. Reporter did not allow further contact.

Other Meds:

Current Illness:

ID: 1572055
Sex: F
Age: 47
State: KS

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: kind of herpes in tongue, palate and throat; skin burn; skin hurt; dry mouth; Oxygen saturation down; swelling of face and eyes; swelling of face and eyes; hives in the chest; scabs on the head; dizziness; blurry vision; pain in the left eye; difficult breathing; loss of smell; vomiting; fatigue; fever 101 F; itchy hands; headache 15 minutes after vaccination; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (vomiting), DYSPNOEA (difficult breathing), ANOSMIA (loss of smell), SWELLING FACE (swelling of face and eyes) and EYE SWELLING (swelling of face and eyes) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20-2A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 in June 2020. Concurrent medical conditions included Asthma and Mite allergy. Concomitant products included ESOMEPRAZOLE for an unknown indication. On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Jan-2021, the patient experienced FATIGUE (fatigue), PYREXIA (fever 101 F), PRURITUS (itchy hands) and HEADACHE (headache 15 minutes after vaccination). On 09-Jan-2021, the patient experienced VOMITING (vomiting), DYSPNOEA (difficult breathing) and ANOSMIA (loss of smell). On 10-Jan-2021, the patient experienced SWELLING FACE (swelling of face and eyes), EYE SWELLING (swelling of face and eyes), URTICARIA (hives in the chest), SCAB (scabs on the head), DIZZINESS (dizziness), VISION BLURRED (blurry vision) and EYE PAIN (pain in the left eye). On 13-Jan-2021, the patient experienced BLISTER (kind of herpes in tongue, palate and throat), SKIN BURNING SENSATION (skin burn), SKIN DISCOMFORT (skin hurt), DRY MOUTH (dry mouth) and OXYGEN SATURATION DECREASED (Oxygen saturation down). The patient was treated with ACETAMINOPHEN for Headache, at a dose of UNK, q6h. At the time of the report, VOMITING (vomiting), DYSPNOEA (difficult breathing), ANOSMIA (loss of smell), SWELLING FACE (swelling of face and eyes), EYE SWELLING (swelling of face and eyes), URTICARIA (hives in the chest), SCAB (scabs on the head), DIZZINESS (dizziness), VISION BLURRED (blurry vision), EYE PAIN (pain in the left eye), BLISTER (kind of herpes in tongue, palate and throat), SKIN BURNING SENSATION (skin burn), SKIN DISCOMFORT (skin hurt), DRY MOUTH (dry mouth), OXYGEN SATURATION DECREASED (Oxygen saturation down), FATIGUE (fatigue), PYREXIA (fever 101 F), PRURITUS (itchy hands) and HEADACHE (headache 15 minutes after vaccination) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 High. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments. Concomitant medications includes medications for allergy and asthma.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds: ESOMEPRAZOLE

Current Illness: Asthma; Mite allergy

ID: 1572056
Sex: F
Age: 49
State: ID

Vax Date: 01/14/2021
Onset Date: 01/15/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Really bad vertigo; Lightheaded; foggy brain; Fatigue; Vomiting; Nausea; Numbness; tingling in her arms and legs; This spontaneous case was reported by a nurse and describes the occurrence of HYPOAESTHESIA (Numbness), PARAESTHESIA (tingling in her arms and legs), VERTIGO (Really bad vertigo), DIZZINESS (Lightheaded) and FEELING ABNORMAL (foggy brain) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced HYPOAESTHESIA (Numbness), PARAESTHESIA (tingling in her arms and legs), FATIGUE (Fatigue), VOMITING (Vomiting) and NAUSEA (Nausea). On 16-Jan-2021, the patient experienced VERTIGO (Really bad vertigo), DIZZINESS (Lightheaded) and FEELING ABNORMAL (foggy brain). On 16-Jan-2021, VERTIGO (Really bad vertigo) had resolved. At the time of the report, HYPOAESTHESIA (Numbness), PARAESTHESIA (tingling in her arms and legs), DIZZINESS (Lightheaded), FEELING ABNORMAL (foggy brain), FATIGUE (Fatigue), VOMITING (Vomiting) and NAUSEA (Nausea) was resolving. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. Treatment for the events included OTC meclizine and paracetamol.

Other Meds:

Current Illness:

ID: 1572057
Sex: F
Age: 63
State: IL

Vax Date: 01/07/2021
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Flu like symptoms; Sore thigh; Fatigue / Hang over; Nausea; This spontaneous case was reported by a medical assistant and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), VACCINATION SITE PAIN (Sore thigh), FATIGUE (Fatigue / Hang over) and NAUSEA (Nausea) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026-L020A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included VITAMINS NOS for an unknown indication. On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), VACCINATION SITE PAIN (Sore thigh), FATIGUE (Fatigue / Hang over) and NAUSEA (Nausea). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), VACCINATION SITE PAIN (Sore thigh), FATIGUE (Fatigue / Hang over) and NAUSEA (Nausea) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No treatment related information has been reported.

Other Meds: VITAMINS NOS

Current Illness:

ID: 1572058
Sex: M
Age:
State:

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: discomfort; little swollen arm; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (discomfort) and VACCINATION SITE SWELLING (little swollen arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 13-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced DISCOMFORT (discomfort) and VACCINATION SITE SWELLING (little swollen arm). At the time of the report, DISCOMFORT (discomfort) and VACCINATION SITE SWELLING (little swollen arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. The treatment history was not provided Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1572059
Sex: F
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: injection site was swollen, red and itching; injection site was swollen, red and itching; injection site was swollen, red and itching; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE SWELLING (injection site was swollen, red and itching), VACCINATION SITE ERYTHEMA (injection site was swollen, red and itching) and VACCINATION SITE PRURITUS (injection site was swollen, red and itching) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (injection site was swollen, red and itching), VACCINATION SITE ERYTHEMA (injection site was swollen, red and itching) and VACCINATION SITE PRURITUS (injection site was swollen, red and itching). At the time of the report, VACCINATION SITE SWELLING (injection site was swollen, red and itching), VACCINATION SITE ERYTHEMA (injection site was swollen, red and itching) and VACCINATION SITE PRURITUS (injection site was swollen, red and itching) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medication was not reported. Treatment medication was not reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1572060
Sex: U
Age:
State: TX

Vax Date: 01/11/2021
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and CHILLS (Chills) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. No Medical History information was reported. On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever) and CHILLS (Chills). At the time of the report, PYREXIA (Fever) and CHILLS (Chills) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. Treatment for the events were not reported. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1572061
Sex: F
Age:
State: TX

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: This spontaneous case reported by a consumer, describes the occurrence of fatigue (became a little tired) and vaccination site pain (it was a little painful in her arm) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 041L20A) for COVID-19 immunization. The patient's past medical history included COVID-19 August 2020. On Jan 11, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Jan 11, 2021, patient experienced fatigue (became a little tired) and vaccination site pain (it was a little painful in her arm). On Jan 13, 2021, fatigue (became a little tired) and vaccination site pain (it was a little painful in her arm) resolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. Treatment provided: Tylenol. Sender's comments: Very limited information regarding these events have been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.

Other Meds:

Current Illness:

ID: 1572062
Sex: M
Age: 67
State: CA

Vax Date: 01/15/2021
Onset Date: 01/16/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Body aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. No Medical History information was reported. On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced PAIN (Body aches). On 18-Jan-2021, PAIN (Body aches) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment related information has been reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1572063
Sex: F
Age:
State: NC

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Discomfort; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (Discomfort) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced DISCOMFORT (Discomfort). At the time of the report, DISCOMFORT (Discomfort) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant and treatment information not provided Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. This case was linked to MOD-2021-008450 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1572064
Sex: F
Age:
State: NY

Vax Date: 01/07/2021
Onset Date: 01/10/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Felt so weak; Didn't feel like eating; Felt a lot of fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Felt so weak), DECREASED APPETITE (Didn't feel like eating) and FATIGUE (Felt a lot of fatigue) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 07-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Jan-2021, the patient experienced FATIGUE (Felt a lot of fatigue). On 13-Jan-2021, the patient experienced ASTHENIA (Felt so weak) and DECREASED APPETITE (Didn't feel like eating). On 11-Jan-2021, FATIGUE (Felt a lot of fatigue) had resolved. On 14-Jan-2021, ASTHENIA (Felt so weak) and DECREASED APPETITE (Didn't feel like eating) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. Treatment information mentions a nutrition drink. Lab tests were not provided. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1572065
Sex: F
Age:
State: NY

Vax Date:
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: severe inflammatoryreaction that was greater than 10cm with redness and pain; severe inflammatoryreaction that was greater than 10cm with redness and pain; severe inflammatoryreaction that was greater than 10cm with redness and pain; had a little fever; This spontaneous case was reported by a physician and describes the occurrence of INFLAMMATION (severe inflammatoryreaction that was greater than 10cm with redness and pain), ERYTHEMA (severe inflammatoryreaction that was greater than 10cm with redness and pain), PAIN (severe inflammatoryreaction that was greater than 10cm with redness and pain) and PYREXIA (had a little fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INFLAMMATION (severe inflammatoryreaction that was greater than 10cm with redness and pain), ERYTHEMA (severe inflammatoryreaction that was greater than 10cm with redness and pain), PAIN (severe inflammatoryreaction that was greater than 10cm with redness and pain) and PYREXIA (had a little fever). At the time of the report, INFLAMMATION (severe inflammatoryreaction that was greater than 10cm with redness and pain), ERYTHEMA (severe inflammatoryreaction that was greater than 10cm with redness and pain), PAIN (severe inflammatoryreaction that was greater than 10cm with redness and pain) and PYREXIA (had a little fever) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were reported. No treatment related information has been reported. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1572066
Sex: F
Age:
State: TX

Vax Date: 12/30/2020
Onset Date: 12/31/2020
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Facial swelling; This spontaneous case was reported by a health care professional and describes the occurrence of SWELLING FACE (Facial swelling) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A20A) for COVID-19 vaccination. Concurrent medical conditions included Dermal filler injection. On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Dec-2020, the patient experienced SWELLING FACE (Facial swelling). At the time of the report, SWELLING FACE (Facial swelling) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Treatment for the event is not provided. Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Further information has been requested; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Further information has been requested

Other Meds:

Current Illness: Dermal filler injection

ID: 1572067
Sex: F
Age:
State: CO

Vax Date: 01/14/2021
Onset Date: 01/14/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concomitant products included VITAMINS NOS for an unknown indication. On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No laboratory data was provided. No treatment information was given. Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded

Other Meds: VITAMINS NOS

Current Illness:

ID: 1572068
Sex: M
Age: 92
State: NC

Vax Date: 01/06/2021
Onset Date: 01/09/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Heart palpitation; Shortness of breath; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Heart palpitation) and DYSPNOEA (Shortness of breath) in a 92-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. No Medical History information was reported. On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jan-2021, the patient experienced PALPITATIONS (Heart palpitation) and DYSPNOEA (Shortness of breath). On 09-Jan-2021, PALPITATIONS (Heart palpitation) and DYSPNOEA (Shortness of breath) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Patient took no medications for treatment nor called any health care provider. No laboratory test was reported. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested

Other Meds:

Current Illness:

ID: 1572069
Sex: F
Age:
State: FL

Vax Date: 01/06/2021
Onset Date: 01/07/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Injection site a little warm; injection site was hard; Injection site itchy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Injection site a little warm), VACCINATION SITE INDURATION (injection site was hard) and VACCINATION SITE PRURITUS (Injection site itchy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 06-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Injection site a little warm), VACCINATION SITE INDURATION (injection site was hard) and VACCINATION SITE PRURITUS (Injection site itchy). At the time of the report, VACCINATION SITE WARMTH (Injection site a little warm), VACCINATION SITE INDURATION (injection site was hard) and VACCINATION SITE PRURITUS (Injection site itchy) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. Laboratory details was not provided. No treatment information was provided. Based on the current available information and temporal association between the use of the product and the start date of the events a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event,s a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1572070
Sex: F
Age: 75
State: TN

Vax Date: 01/05/2021
Onset Date: 01/05/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Itching on the night; Hot to the touch; Swollen; It get red; Arm was sore for one day; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was sore for one day), PRURITUS (Itching on the night), SKIN WARM (Hot to the touch), PERIPHERAL SWELLING (Swollen) and ERYTHEMA (It get red) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No prior medical history was reported.). On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm was sore for one day). On 13-Jan-2021, the patient experienced PRURITUS (Itching on the night), SKIN WARM (Hot to the touch), PERIPHERAL SWELLING (Swollen) and ERYTHEMA (It get red). On 06-Jan-2021, PAIN IN EXTREMITY (Arm was sore for one day) had resolved. At the time of the report, PRURITUS (Itching on the night), SKIN WARM (Hot to the touch), PERIPHERAL SWELLING (Swollen) and ERYTHEMA (It get red) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Treatment information was not provided. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1572071
Sex: F
Age: 57
State: KY

Vax Date: 01/06/2021
Onset Date: 01/14/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Lymph nodes seam swollen under the right arm; At the injection site it is red; At the injection site it is warm; At the injection site it is swollen; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 15-Jan-2021 and was forwarded to Moderna on 15-Jan-2021. This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Lymph nodes seam swollen under the right arm), VACCINATION SITE ERYTHEMA (At the injection site it is red), VACCINATION SITE WARMTH (At the injection site it is warm) and VACCINATION SITE SWELLING (At the injection site it is swollen) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history reported). On 06-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 14-Jan-2021, the patient experienced LYMPHADENOPATHY (Lymph nodes seam swollen under the right arm), VACCINATION SITE ERYTHEMA (At the injection site it is red), VACCINATION SITE WARMTH (At the injection site it is warm) and VACCINATION SITE SWELLING (At the injection site it is swollen). At the time of the report, LYMPHADENOPATHY (Lymph nodes seam swollen under the right arm), VACCINATION SITE ERYTHEMA (At the injection site it is red), VACCINATION SITE WARMTH (At the injection site it is warm) and VACCINATION SITE SWELLING (At the injection site it is swollen) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment information was not provided. Concomitant medication was not provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1572072
Sex: F
Age:
State:

Vax Date: 01/13/2021
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Mild fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Mild fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 13-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Mild fever). At the time of the report, PYREXIA (Mild fever) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. Concomitant medication was not reported. Treatment medication was not reported. Reporter did not allow further contact Most recent FOLLOW-UP information incorporated above includes: On 26-Jan-2021: Event outcome and AE for husband reported. On 12-Apr-2021: Outgoing call to obtain email address, voice message left.

Other Meds:

Current Illness:

ID: 1572073
Sex: F
Age:
State: TX

Vax Date: 12/30/2020
Onset Date: 12/30/2020
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: high sensitivity to cold; chills; pain in the arm; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (high sensitivity to cold), CHILLS (chills) and PAIN IN EXTREMITY (pain in the arm) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. No Medical History information was reported. On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Dec-2020, the patient experienced CHILLS (chills) and PAIN IN EXTREMITY (pain in the arm). On 11-Jan-2021, the patient experienced FEELING COLD (high sensitivity to cold). On 31-Dec-2020, CHILLS (chills) and PAIN IN EXTREMITY (pain in the arm) had resolved. At the time of the report, FEELING COLD (high sensitivity to cold) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Treatment included ibuprofen. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1572074
Sex: M
Age: 71
State: TX

Vax Date: 01/12/2021
Onset Date: 01/12/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Chills; Headache; This spontaneous case was reported by a patient and describes the occurrence of CHILLS (Chills) and HEADACHE (Headache) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 12-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Jan-2021, the patient experienced CHILLS (Chills) and HEADACHE (Headache). In January 2021, CHILLS (Chills) and HEADACHE (Headache) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No laboratory data was provided. Treatment information included ibuprofen was reported. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1572075
Sex: F
Age: 75
State:

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Rash is itchy on the injection site; Rash on injection site, the size of a couple of quarters; Rash is raised on the injection site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE PRURITUS (Rash is itchy on the injection site), VACCINATION SITE RASH (Rash on injection site, the size of a couple of quarters) and VACCINATION SITE SWELLING (Rash is raised on the injection site) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. No Medical History information was reported. On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Rash is itchy on the injection site), VACCINATION SITE RASH (Rash on injection site, the size of a couple of quarters) and VACCINATION SITE SWELLING (Rash is raised on the injection site). At the time of the report, VACCINATION SITE PRURITUS (Rash is itchy on the injection site), VACCINATION SITE RASH (Rash on injection site, the size of a couple of quarters) and VACCINATION SITE SWELLING (Rash is raised on the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication included blood thinner. Treatment included ice pack.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1572076
Sex: F
Age: 48
State: CA

Vax Date: 01/13/2021
Onset Date: 01/14/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. No Medical History information was reported. On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced HEADACHE (headache). At the time of the report, HEADACHE (headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Tylenol 2 tablets was taken as treatment for headache. Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1572077
Sex: F
Age:
State: CA

Vax Date: 12/30/2020
Onset Date: 12/30/2020
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: sore in her arm (injection site); redness from allergic reaction to bandaid; remarkable itchy allergic reaction to bandaid (latex); This spontaneous case was reported by an other health care professional and describes the occurrence of in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. No Medical History information was reported. On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Laboratory details was not provided. Treatment information was not provided. Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1572078
Sex: F
Age: 60
State:

Vax Date: 01/05/2021
Onset Date: 01/05/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Lingering soreness in my arm up to my neck now; Diarrhea; Fever; Tested positive for Covid; Felt like i got cold; sore arm at moderate level of pain; Chills; Cramps in my feet; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 14-Jan-2021 and was forwarded to Moderna on 15-Jan-2021. This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION SITE PAIN (sore arm at moderate level of pain), CHILLS (Chills), MUSCLE SPASMS (Cramps in my feet), NECK PAIN (Lingering soreness in my arm up to my neck now) and NASOPHARYNGITIS (Felt like i got cold) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event. Concomitant products included LEVOTHYROXINE and ESTRADIOL. On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jan-2021, the patient experienced VACCINATION SITE PAIN (sore arm at moderate level of pain), CHILLS (Chills) and MUSCLE SPASMS (Cramps in my feet). On 10-Jan-2021, the patient experienced NASOPHARYNGITIS (Felt like i got cold). On 11-Jan-2021, the patient experienced DIARRHOEA (Diarrhea), PYREXIA (Fever) and SARS-COV-2 TEST POSITIVE (Tested positive for Covid). On an unknown date, the patient experienced NECK PAIN (Lingering soreness in my arm up to my neck now). On 06-Jan-2021, CHILLS (Chills) and MUSCLE SPASMS (Cramps in my feet) had resolved. On 07-Jan-2021, VACCINATION SITE PAIN (sore arm at moderate level of pain) outcome was unknown. At the time of the report, NECK PAIN (Lingering soreness in my arm up to my neck now), NASOPHARYNGITIS (Felt like i got cold), DIARRHOEA (Diarrhea), PYREXIA (Fever) and SARS-COV-2 TEST POSITIVE (Tested positive for Covid) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Jan-2021, SARS-CoV-2 test: positive Positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment included over the counter advil and Tylenol.

Other Meds: LEVOTHYROXINE; ESTRADIOL

Current Illness:

ID: 1572079
Sex: F
Age: 49
State: TX

Vax Date: 01/03/2021
Onset Date: 01/03/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Now its itching very bad at the injection site; It hurts around the injection site; It is really really warm to touch; Itchy at the injection site; Redness is back again,red circle is getting bigger every day; slight headache; Left arm sore; Red circle around injection site; warm to touch; Bruise around injection site; Hard around injection site; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 14-Jan-2021 and was forwarded to Moderna on 15-Jan-2021. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (warm to touch), VACCINATION SITE WARMTH (It is really really warm to touch), VACCINATION SITE PRURITUS (Now its itching very bad at the injection site), HEADACHE (slight headache) and VACCINATION SITE PAIN (It hurts around the injection site) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Thyroid. Concomitant products included VENLAFAXINE and VITAMINS NOS for an unknown indication. On 03-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 03-Jan-2021, the patient experienced VACCINATION SITE WARMTH (warm to touch). On 11-Jan-2021, the patient experienced HEADACHE (slight headache). On 12-Jan-2021, the patient experienced VACCINATION SITE WARMTH (It is really really warm to touch), VACCINATION SITE PAIN (It hurts around the injection site) and VACCINATION SITE ERYTHEMA (Redness is back again,red circle is getting bigger every day). On 14-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Now its itching very bad at the injection site). At the time of the report, VACCINATION SITE WARMTH (warm to touch) had resolved and VACCINATION SITE WARMTH (It is really really warm to touch), VACCINATION SITE PRURITUS (Now its itching very bad at the injection site), HEADACHE (slight headache), VACCINATION SITE PAIN (It hurts around the injection site) and VACCINATION SITE ERYTHEMA (Redness is back again,red circle is getting bigger every day) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment includes cortisol cream and ibuprofen since Tuesday (twice a day since 12jan2021) Reporter did not allow further contact

Other Meds: VENLAFAXINE; VITAMINS NOS

Current Illness:

ID: 1572080
Sex: F
Age: 43
State: FL

Vax Date: 01/12/2021
Onset Date: 01/12/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: mild phlegm; Body temperature goes from hot to cold; Chills; Headache; low grade fever; muscle ache; tingling around the neck; This spontaneous case was reported by a patient and describes the occurrence of PARAESTHESIA (tingling around the neck), PRODUCTIVE COUGH (mild phlegm), FEELING OF BODY TEMPERATURE CHANGE (Body temperature goes from hot to cold), CHILLS (Chills) and HEADACHE (Headache) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Jan-2021, the patient experienced PARAESTHESIA (tingling around the neck), CHILLS (Chills), HEADACHE (Headache), PYREXIA (low grade fever) and MYALGIA (muscle ache). On 14-Jan-2021, the patient experienced PRODUCTIVE COUGH (mild phlegm) and FEELING OF BODY TEMPERATURE CHANGE (Body temperature goes from hot to cold). The patient was treated with IBUPROFEN (ADVIL 12 HOUR) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, PARAESTHESIA (tingling around the neck), PRODUCTIVE COUGH (mild phlegm), FEELING OF BODY TEMPERATURE CHANGE (Body temperature goes from hot to cold), CHILLS (Chills), HEADACHE (Headache), PYREXIA (low grade fever) and MYALGIA (muscle ache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medication details were not reported by the reporter. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1572081
Sex: F
Age: 41
State: WA

Vax Date: 01/06/2021
Onset Date: 01/14/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Warm touch at the injection site; Itchy at the injection site; Red knot at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm touch at the injection site), VACCINATION SITE PRURITUS (Itchy at the injection site) and VACCINATION SITE INDURATION (Red knot at the site of injection) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. No Medical History information was reported. On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Warm touch at the injection site), VACCINATION SITE PRURITUS (Itchy at the injection site) and VACCINATION SITE INDURATION (Red knot at the site of injection). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL ITCH) ongoing since an unknown date at an unspecified dose and frequency. In January 2021, VACCINATION SITE INDURATION (Red knot at the site of injection) was resolving. At the time of the report, VACCINATION SITE WARMTH (Warm touch at the injection site) and VACCINATION SITE PRURITUS (Itchy at the injection site) was resolving. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medication details were not reported by the reporter. Treatment included topical steroid cream.

Other Meds:

Current Illness:

ID: 1572082
Sex: M
Age: 70
State: FL

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Left Arm Hurts; Headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Left Arm Hurts) and HEADACHE (Headache) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. Concomitant products included PARACETAMOL (TYLENOL), ASPIRIN ALUMINUM, TURMERIC [CURCUMA LONGA RHIZOME] and COENZYME Q10 [UBIDECARENONE] for an unknown indication. On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced VACCINATION SITE PAIN (Left Arm Hurts) and HEADACHE (Headache). At the time of the report, VACCINATION SITE PAIN (Left Arm Hurts) and HEADACHE (Headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment of the event included Paracetamol, 1 glass of wine and 2 beers. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested

Other Meds: TYLENOL; ASPIRIN ALUMINUM; TURMERIC [CURCUMA LONGA RHIZOME]; COENZYME Q10 [UBIDECARENONE]

Current Illness:

ID: 1572083
Sex: F
Age: 49
State: NJ

Vax Date: 01/14/2021
Onset Date: 01/14/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Loss of range of motion in her left arm; Arm pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (Loss of range of motion in her left arm) and VACCINATION SITE PAIN (Arm pain) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (Loss of range of motion in her left arm) and VACCINATION SITE PAIN (Arm pain). At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (Loss of range of motion in her left arm) and VACCINATION SITE PAIN (Arm pain) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No conmeds reported. Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1572084
Sex: F
Age: 45
State: KS

Vax Date: 01/14/2021
Onset Date: 01/14/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches), NECK PAIN (Neck was a little sore), BACK PAIN (Back hurting), TEMPERATURE REGULATION DISORDER (Trouble getting warm) and ARTHRALGIA (Joint pain) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Type 1 diabetes mellitus since an unknown date and COVID-19 in December 2020. On 14-Jan-2021 at 8:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced NECK PAIN (Neck was a little sore), BACK PAIN (Back hurting), HEADACHE (Hadache) and FATIGUE (Tired). On 14-Jan-2021 at 6:00 PM, the patient experienced PAIN (Body aches), TEMPERATURE REGULATION DISORDER (Trouble getting warm), ARTHRALGIA (Joint pain) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN (Body aches), NECK PAIN (Neck was a little sore), BACK PAIN (Back hurting), TEMPERATURE REGULATION DISORDER (Trouble getting warm), ARTHRALGIA (Joint pain), CHILLS (Chills), HEADACHE (Hadache) and FATIGUE (Tired) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Jan-2021, Blood glucose increased: elevated (High) Blood sugar is elevated. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication was not reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness: Type 1 diabetes mellitus

ID: 1572085
Sex: F
Age: 64
State:

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Shaking/tremor; Headaches; Body aches; Temperature a 100; Chills; Nausea; This spontaneous case was reported by a nurse and describes the occurrence of TREMOR (Shaking/tremor), HEADACHE (Headaches), MYALGIA (Body aches), PYREXIA (Temperature a 100) and CHILLS (Chills) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 in April 2020. Concurrent medical conditions included Thyroid disorder NOS. On 13-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jan-2021, the patient experienced TREMOR (Shaking/tremor), HEADACHE (Headaches), MYALGIA (Body aches), PYREXIA (Temperature a 100), CHILLS (Chills) and NAUSEA (Nausea). On 14-Jan-2021, TREMOR (Shaking/tremor), PYREXIA (Temperature a 100), CHILLS (Chills) and NAUSEA (Nausea) had resolved. At the time of the report, HEADACHE (Headaches) and MYALGIA (Body aches) had not resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. The events shaking, chills, with nausea, tremors and temperature a 100 were resolved on 14 Jan 2021 Treatment for the event included paracetamol. Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness: Thyroid disorder NOS

ID: 1572086
Sex: F
Age: 83
State: OK

Vax Date: 01/06/2021
Onset Date: 01/13/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Rash up and down whole arm; Rash over arms Itching really bad; This spontaneous case was reported by a consumer and describes the occurrence of in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included Neuropathy (Neuropathy) and Arthritis (Arthritis.). Concurrent medical conditions included Diabetes (Diabetes) and Allergy (Seasonal allergies). Concomitant products included PIPERAZINE CITRATE (CITRAZINE), LEVOCETIRIZINE DIHYDROCHLORIDE (LEVOMER [LEVOCETIRIZINE DIHYDROCHLORIDE]), VITAMIN 15 and GABAPENTIN for an unknown indication. On 06-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Laboratory details were not provided. Treatment information was provided as cortisone. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds: CITRAZINE; LEVOMER [LEVOCETIRIZINE DIHYDROCHLORIDE]; VITAMIN 15; GABAPENTIN

Current Illness: Allergy (Seasonal allergies); Diabetes (Diabetes)

ID: 1572087
Sex: F
Age: 68
State: NJ

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Headache; This spontaneous case was reported by a patient and describes the occurrence of HEADACHE (Headache) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. No Medical History information was reported. On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jan-2021, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. Treatment for the event, was not reported. Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1572088
Sex: F
Age: 40
State: TX

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Pain on her chest; Fever; Headache; Chills; soreness; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Pain on her chest), PYREXIA (Fever), HEADACHE (Headache), CHILLS (Chills) and VACCINATION SITE PAIN (soreness) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. Concurrent medical conditions included Blood pressure. Concomitant products included LISINOPRIL for Blood pressure. On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced PYREXIA (Fever), HEADACHE (Headache), CHILLS (Chills) and VACCINATION SITE PAIN (soreness). On 14-Jan-2021, the patient experienced CHEST PAIN (Pain on her chest). At the time of the report, CHEST PAIN (Pain on her chest), PYREXIA (Fever), HEADACHE (Headache), CHILLS (Chills) and VACCINATION SITE PAIN (soreness) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested

Other Meds: LISINOPRIL

Current Illness: Blood pressure

ID: 1572089
Sex: F
Age: 36
State: MA

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Hives; Extremely itchy; The rash was still lingering and still a litle bit of an itch; Rash on her bodystarting at her chest down to her knees then radiating to her back towards her buttocks; This spontaneous case was reported by a pharmacist and describes the occurrence of URTICARIA (Hives), PRURITUS (Extremely itchy), RASH PRURITIC (The rash was still lingering and still a litle bit of an itch) and RASH (Rash on her bodystarting at her chest down to her knees then radiating to her back towards her buttocks) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. No Medical History information was reported. On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced URTICARIA (Hives), PRURITUS (Extremely itchy), RASH PRURITIC (The rash was still lingering and still a litle bit of an itch) and RASH (Rash on her bodystarting at her chest down to her knees then radiating to her back towards her buttocks). At the time of the report, URTICARIA (Hives), PRURITUS (Extremely itchy) and RASH (Rash on her bodystarting at her chest down to her knees then radiating to her back towards her buttocks) was resolving and RASH PRURITIC (The rash was still lingering and still a litle bit of an itch) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. The patient was treated with Benadryl (diphenhydramine). Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1572090
Sex: M
Age: 79
State: FL

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Back pain; Vaccination site hard; Headache; Injection site pain; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Back pain), VACCINATION SITE INDURATION (Vaccination site hard), HEADACHE (Headache) and VACCINATION SITE PAIN (Injection site pain) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. D391L20A) for COVID-19 vaccination. The patient's past medical history included Laminectomy spinal in 1998. On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced BACK PAIN (Back pain), VACCINATION SITE INDURATION (Vaccination site hard), HEADACHE (Headache) and VACCINATION SITE PAIN (Injection site pain). The patient was treated with ROSUVASTATIN ongoing since an unknown date at a dose of 20 mg. On 14-Jan-2021, BACK PAIN (Back pain), HEADACHE (Headache) and VACCINATION SITE PAIN (Injection site pain) had resolved. At the time of the report, VACCINATION SITE INDURATION (Vaccination site hard) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. The patient was treated with Aleve (naproxen). Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.

Other Meds:

Current Illness:

ID: 1572091
Sex: F
Age: 35
State: NJ

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Behind ears hurts/tense; Blood pressure; blood sugar was 54mg/dl; blood pressure was high 140/80, 149/96 mmHg; Dizziness; severe headache; Lightheaded; This spontaneous case was reported by a medical assistant (subsequently medically confirmed) and describes the occurrence of DIZZINESS (Lightheaded), HYPOGLYCAEMIA (blood sugar was 54mg/dl), HYPERTENSION (blood pressure was high 140/80, 149/96 mmHg), DIZZINESS (Dizziness) and EAR PAIN (Behind ears hurts/tense) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event (Medical history not reported.), Blood pressure low and SARS-CoV-2 test. On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2021, the patient experienced DIZZINESS (Lightheaded) and HEADACHE (severe headache). On 08-Jan-2021, the patient experienced HYPOGLYCAEMIA (blood sugar was 54mg/dl), HYPERTENSION (blood pressure was high 140/80, 149/96 mmHg) and DIZZINESS (Dizziness). On 14-Jan-2021, the patient experienced EAR PAIN (Behind ears hurts/tense) and BLOOD PRESSURE MEASUREMENT (Blood pressure). At the time of the report, DIZZINESS (Lightheaded), HYPOGLYCAEMIA (blood sugar was 54mg/dl), HYPERTENSION (blood pressure was high 140/80, 149/96 mmHg), DIZZINESS (Dizziness), EAR PAIN (Behind ears hurts/tense), BLOOD PRESSURE MEASUREMENT (Blood pressure) and HEADACHE (severe headache) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Jan-2021, Blood glucose: 54 mg/dl (Low) low. On 08-Jan-2021, Blood pressure measurement: 140/80 mmHg (High) high. On 14-Jan-2021, Blood pressure measurement: 149/96 mmHg (High) high. On 14-Jan-2021, Heart rate: 67 (normal) breathes per minute. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No con meds reported. Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1572092
Sex: M
Age: 64
State: PA

Vax Date: 01/12/2021
Onset Date: 01/12/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Soreness at the vaccination site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness at the vaccination site) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. No Medical History information was reported. On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced VACCINATION SITE PAIN (Soreness at the vaccination site). On 14-Jan-2021, VACCINATION SITE PAIN (Soreness at the vaccination site) had resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment for the event as reported, he was going to take ibuprofen for the pain but forgot. Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1572093
Sex: F
Age: 75
State: GA

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: dizziness; incoherent; loss of balance; All common side effects besides nausea and vomiting; fatigue; injection site tenderness; This spontaneous case was reported by a consumer and describes the occurrence of INCOHERENT (incoherent), BALANCE DISORDER (loss of balance), ADVERSE EVENT (All common side effects besides nausea and vomiting), VACCINATION SITE PAIN (injection site tenderness) and FATIGUE (fatigue) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced VACCINATION SITE PAIN (injection site tenderness). On 14-Jan-2021, the patient experienced INCOHERENT (incoherent), BALANCE DISORDER (loss of balance), ADVERSE EVENT (All common side effects besides nausea and vomiting) and FATIGUE (fatigue). At the time of the report, INCOHERENT (incoherent), BALANCE DISORDER (loss of balance), ADVERSE EVENT (All common side effects besides nausea and vomiting), VACCINATION SITE PAIN (injection site tenderness) and FATIGUE (fatigue) was resolving. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. This case was linked to MOD-2021-008002 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1572094
Sex: M
Age:
State: MS

Vax Date: 01/09/2021
Onset Date: 01/11/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Chest tight; Short of breath; Mouth breathing; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Chest tight), DYSPNOEA (Short of breath) and MOUTH BREATHING (Mouth breathing) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L2D8) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included OMEPRAZOLE for an unknown indication. On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jan-2021, the patient experienced CHEST DISCOMFORT (Chest tight), DYSPNOEA (Short of breath) and MOUTH BREATHING (Mouth breathing). At the time of the report, CHEST DISCOMFORT (Chest tight), DYSPNOEA (Short of breath) and MOUTH BREATHING (Mouth breathing) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. Additional concomitant medications reported were blood pressure, diabetes, prostate medicine. No treatment information was provided. Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.

Other Meds: OMEPRAZOLE

Current Illness:

ID: 1572095
Sex: F
Age: 75
State: GA

Vax Date: 01/12/2021
Onset Date: 01/13/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Injection site started to feel itchy; Warm to touch; A spontaneous report was received from a consumer concerning a 75-year-old , female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced injection site itchy and injection site warm. The patient's medical history, was not provided.Concomitant medications was not reported. On 12 Jan 2021 prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: unknown) for prophylaxis of COVID-19 infection. On 13 Jan 2021 the patient felt injection site itchy and injection site warm. Treatment for the events was unknown. Action taken with mRNA-1273 in response to the events was not reported. The outcome of the events injection site itchy and injection site warm was unknown.

Other Meds:

Current Illness:

ID: 1572096
Sex: F
Age: 84
State:

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: My arm is very swollen; My arm is red; My arm is itchy; Knocked out on Tuesday January 12, 2021, I slept the whole day; Not much appetite; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Knocked out on Tuesday January 12, 2021, I slept the whole day), DECREASED APPETITE (Not much appetite), PERIPHERAL SWELLING (My arm is very swollen), ERYTHEMA (My arm is red) and PRURITUS (My arm is itchy) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Hypertension and Heart disease, unspecified. On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jan-2021, the patient experienced DECREASED APPETITE (Not much appetite). On 12-Jan-2021, the patient experienced SOMNOLENCE (Knocked out on Tuesday January 12, 2021, I slept the whole day). On an unknown date, the patient experienced PERIPHERAL SWELLING (My arm is very swollen), ERYTHEMA (My arm is red) and PRURITUS (My arm is itchy). At the time of the report, SOMNOLENCE (Knocked out on Tuesday January 12, 2021, I slept the whole day), DECREASED APPETITE (Not much appetite), PERIPHERAL SWELLING (My arm is very swollen), ERYTHEMA (My arm is red) and PRURITUS (My arm is itchy) was resolving. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Treatment for the events included paracetamol. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness: Heart disease, unspecified; Hypertension

ID: 1572097
Sex: F
Age: 66
State:

Vax Date: 01/13/2021
Onset Date: 01/15/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Warm sensation at the injection site; Injection site itchiness; Injection site redness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm sensation at the injection site), VACCINATION SITE PRURITUS (Injection site itchiness) and VACCINATION SITE ERYTHEMA (Injection site redness) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032H20A) for COVID-19 vaccination. The patient's past medical history included No adverse event (No reported medical history.). On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Warm sensation at the injection site), VACCINATION SITE PRURITUS (Injection site itchiness) and VACCINATION SITE ERYTHEMA (Injection site redness). At the time of the report, VACCINATION SITE WARMTH (Warm sensation at the injection site), VACCINATION SITE PRURITUS (Injection site itchiness) and VACCINATION SITE ERYTHEMA (Injection site redness) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. No treatment was received. Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1572098
Sex: M
Age: 52
State: ID

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Backache; Headache; Pain in the injection site; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Backache), HEADACHE (Headache) and INJECTION SITE PAIN (Pain in the injection site) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination. The patient's past medical history included COVID-19 in April 2020. On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jan-2021, the patient experienced BACK PAIN (Backache), HEADACHE (Headache) and INJECTION SITE PAIN (Pain in the injection site). At the time of the report, BACK PAIN (Backache), HEADACHE (Headache) and INJECTION SITE PAIN (Pain in the injection site) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications reported by investigator o No treatment medications provided by the reporter.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.

Other Meds:

Current Illness:

ID: 1572099
Sex: F
Age:
State:

Vax Date:
Onset Date: 01/13/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Loose bowel; Runny eyes; Runny nose; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Loose bowel), LACRIMATION INCREASED (Runny eyes) and RHINORRHOEA (Runny nose) in a 93-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event (Medical history not reported.). On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced DIARRHOEA (Loose bowel), LACRIMATION INCREASED (Runny eyes) and RHINORRHOEA (Runny nose). At the time of the report, DIARRHOEA (Loose bowel), LACRIMATION INCREASED (Runny eyes) and RHINORRHOEA (Runny nose) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. Treatment information was not provided. Company Comment: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.

Other Meds:

Current Illness:

ID: 1572100
Sex: F
Age: 42
State: MI

Vax Date: 01/07/2021
Onset Date: 01/09/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: shingles; itchy hives on the stomach; soreness at the injection site; redness at the injection site; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION SITE PAIN (soreness at the injection site), VACCINATION SITE ERYTHEMA (redness at the injection site), URTICARIA (itchy hives on the stomach) and HERPES ZOSTER (shingles) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. No Medical History information was reported. On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jan-2021, the patient experienced VACCINATION SITE PAIN (soreness at the injection site) and VACCINATION SITE ERYTHEMA (redness at the injection site). On 15-Jan-2021, the patient experienced URTICARIA (itchy hives on the stomach). On 22-Jan-2021, the patient experienced HERPES ZOSTER (shingles). The patient was treated with PREDNISONE for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (soreness at the injection site), VACCINATION SITE ERYTHEMA (redness at the injection site), URTICARIA (itchy hives on the stomach) and HERPES ZOSTER (shingles) was resolving. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment medications include antiviral medication. Concomitant product use was not provided by the reporter.

Other Meds:

Current Illness:

ID: 1572101
Sex: F
Age: 24
State: NY

Vax Date: 02/10/2021
Onset Date: 02/11/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: rash appearing on my arm yesterday where I got the vaccine; soreness; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE RASH (rash appearing on my arm yesterday where I got the vaccine) and INJECTION SITE PAIN (soreness) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. Concurrent medical conditions included Injection site rash on 17-Feb-2021 and Pain injection site on 11-Feb-2021. On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced INJECTION SITE PAIN (soreness). On 17-Feb-2021, the patient experienced INJECTION SITE RASH (rash appearing on my arm yesterday where I got the vaccine). On 12-Feb-2021, INJECTION SITE PAIN (soreness) outcome was unknown. At the time of the report, INJECTION SITE RASH (rash appearing on my arm yesterday where I got the vaccine) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment and concomitant product use were not provided by the reporter.

Other Meds:

Current Illness: Pain injection site

ID: 1572102
Sex: F
Age: 50
State:

Vax Date: 01/09/2021
Onset Date: 01/10/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: itchiness and redness at the injection site; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itchiness and redness at the injection site) and FATIGUE (fatigue) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination. No Medical History information was reported. On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Jan-2021, the patient experienced FATIGUE (fatigue). On 16-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (itchiness and redness at the injection site). On 14-Jan-2021, FATIGUE (fatigue) had resolved. At the time of the report, VACCINATION SITE PRURITUS (itchiness and redness at the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment include cortisone cream.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 636,615

Page last modified: 03 October 2021 5:28pm